- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01245803
Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS (AVATAR)
November 22, 2010 updated by: Beijing Anzhen Hospital
Acute Rosuvastatin for Preventing Myocardial Damage in Patients With Acute Coronary Syndrome
Rosuvastatin reload may prevent myocardial damage in ACS patients undergoing PCI
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100029
- Recruiting
- the 28th division, Beijing Anzhen Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18-75 year old
- diagnosed as acute coronary syndrome
- Plan to PCI
Exclusion Criteria:
- STEMI patient
- emergency PCI(<2h) for NSTE-ACS
- History of liver disease and myopathy (ALT/AST>3 x upper limit of normal,CK>5 x upper limit of normal)
- TG>500mg/dl,CCr<30ml/min
- inflammatory disease
- allergic to rosuvastatin
- nephrotic syndrome,hypothyroidism,systemic lupus erythematosus,myeloma,et.al.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: rosuvastatin,one month,lipid lowering
additional rosuvastatin(10mg) is given at 18hr and 4-6hr before PCI
|
additional rosuvastatin (10mg p.o.)is given at 18 hours and 4-6 hours before PCI
|
Placebo Comparator: sugar pill, one month
sugar pill is given 18-24hr and 4-6hr before PCI as control
|
sugar pill is given 18-24hr and 4-6hr before PCI as control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
peri-procedural myocardial damage
Time Frame: 48 hours after PCI
|
48 hours after PCI
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
MACE
Time Frame: 30 days after PCI
|
30 days after PCI
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2010
Primary Completion (Anticipated)
April 1, 2011
Study Completion (Anticipated)
May 1, 2011
Study Registration Dates
First Submitted
November 22, 2010
First Submitted That Met QC Criteria
November 22, 2010
First Posted (Estimate)
November 23, 2010
Study Record Updates
Last Update Posted (Estimate)
November 23, 2010
Last Update Submitted That Met QC Criteria
November 22, 2010
Last Verified
July 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Disease
- Syndrome
- Acute Coronary Syndrome
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Antimetabolites
- Anticholesteremic Agents
- Hypolipidemic Agents
- Lipid Regulating Agents
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Rosuvastatin Calcium
Other Study ID Numbers
- 6998
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndrome
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
Meditrix CorpNational University of Ireland, Galway, Ireland; Boston Scientific Japan K.K.; Fujita Health UniversityRecruitingChronic Coronary Syndrome | Non ST Segment Elevation Acute Coronary SyndromeJapan, Ireland
-
OrbusNeichDuke Clinical Research Institute; OrbusNeich Medical K.K.CompletedCoronary Arteriosclerosis | Non ST Segment Elevation Acute Coronary SyndromeUnited States, Japan
-
Medical University of WarsawRecruitingAcute Coronary Syndrome | Chronic Coronary Syndrome | Non ST Segment Elevation Acute Coronary SyndromePoland
-
Niguarda HospitalCompletedAcute Coronary Syndrome With ST Elevation on Electrocardiogram | Acute Coronary Syndrome Without ST Elevation on Electrocardiogram | Noncritical Coronary Artery Disease Coronary Stenosis Less Than 50 Per Cent | Aortic AneurysmsItaly
-
Sohag UniversityRecruitingLeft Main Coronary Artery Disease With Acute Coronary SyndromeEgypt
-
Eli Lilly and CompanyDaiichi Sankyo, Inc.CompletedCoronary Arteriosclerosis | Acute Coronary SyndromesUnited States
-
University of PatrasCompletedCoronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS)Greece
-
Deutsches Herzzentrum MuenchenDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)CompletedAcute Coronary Syndrome (ACS)Germany, Italy
-
Northwestern UniversityTerminatedACS - Acute Coronary SyndromeUnited States
Clinical Trials on additional rosuvastatin loading
-
Universidade Federal do Rio Grande do NorteCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Completed
-
Daping Hospital and the Research Institute of Surgery...AstraZenecaUnknown
-
University of Sao PauloUnknownPrimary Total Hip ArthroplastyBrazil
-
University of Alabama at BirminghamMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases...CompletedDiabetes Mellitus, Type 2 | Diabetes MellitusUnited States
-
Postgraduate Institute of Dental Sciences RohtakCompleted
-
University of BernRecruitingEffect of Placing the Implant Crown on the Implant on the Same Day as the Implant vs. 4 Weeks Later.Lower Molar Requiring ExtractionSwitzerland
-
Universidad de GranadaCompleted
-
Fölktandvården Skåne ABCompleted
-
Medical University of GrazNeoss Ltd., Harrogate, UKCompletedEdentulous JawAustria